Blackrock Neurotech —

Blackrock Neurotech | Empowered by Thought

Blackrock Neurotech innovative brain technologies provide new hope for people with paralysis & other neurological disorders.

Overview

Blackrock Neurotech is a company specializing in brain-computer interface (BCI) technology, headquartered in Salt Lake City, Utah. The company develops neural implants aimed at restoring function and independence for individuals with neurological disorders, including ALS, Alzheimer’s, Parkinson’s, epilepsy, and paralysis. Blackrock Neurotech has established partnerships with over 500 global institutions to advance research and innovation in neuroscience. Its BCI systems have been in use since 2004, allowing patients to regain movement and communication abilities, with users collectively benefiting from over 30,000 days of use. The company's first commercial BCI, MoveAgain, received Breakthrough Designation from the FDA in 2021 and is anticipated to be available in 2023.

Website LinkedIn Careers Crunchbase

Details

Category: Medical Equipment Manufacturing
Headquarters: Salt Lake City, Utah
Type: Privately Held
Founded: 2008
Followers: 39,141
Specialties: neuroscience, brain-computer interface, bci, neurotech, medical devices, neurotechnology, medical technology, biotechnology, brain chip, neurology, tech, biotech, medtech, brain computer interface, Utah Array, NeuroPort Array, Paralysis, Neurological disorders, Restoration, Communication, Mobility, Touch, and Sensation
Locations: n/a Salt Lake City, Utah 84108, US

Funding

Total rounds: 2
Last round: Convertible note, Dec 1, 2021